Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVR Anteris Technologies Global	$3.80 +2.4%	$4.29	$2.34 ▼ $8.79	$137.04M	N/A	299,459 shs	209,036 shs
AXGN AxoGen	$10.92 -1.3%	$11.70	$7.33 ▼ $21.00	$497.80M	1.04	492,421 shs	169,683 shs
KIDS OrthoPediatrics	$22.47 +1.5%	$21.49	$19.52 ▼ $35.99	$545.97M	1.1	199,192 shs	90,392 shs
RXST RxSight	$13.20 +0.4%	$14.49	$12.53 ▼ $58.23	$530.31M	1.21	718,054 shs	927,254 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVR Anteris Technologies Global	0.00%	-6.40%	-23.39%	+18.01%	+379,999,900.00%
AXGN AxoGen	0.00%	+4.00%	+1.11%	-32.68%	+42.56%
KIDS OrthoPediatrics	0.00%	+5.12%	+7.69%	-1.04%	-24.97%
RXST RxSight	0.00%	+4.18%	-11.53%	-18.83%	-76.84%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
AXGN AxoGen	2.0264 of 5 stars	3.5	2.0	0.0	0.0	0.0	2.5	0.6
KIDS OrthoPediatrics	3.9125 of 5 stars	3.4	2.0	0.0	3.9	0.0	3.3	0.6
RXST RxSight	1.7535 of 5 stars	3.2	1.0	0.0	0.0	1.9	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVR Anteris Technologies Global	3.00	Buy	$16.50	334.21% Upside
AXGN AxoGen	3.00	Buy	$24.50	124.36% Upside
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	59.51% Upside
RXST RxSight	2.30	Hold	$37.90	187.14% Upside

Current Analyst Ratings Breakdown

Latest AVR, KIDS, RXST, and AXGN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/19/2025	RXST RxSight	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$17.00 ➝ $25.00
5/13/2025	AXGN AxoGen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$26.00 ➝ $24.00
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/15/2025	RXST RxSight	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$18.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/9/2025	RXST RxSight	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$45.00 ➝ $16.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00

(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVR Anteris Technologies Global	$2.70M	50.75	N/A	N/A	$1.74 per share	2.18
AXGN AxoGen	$187.34M	2.65	N/A	N/A	$2.36 per share	4.63
KIDS OrthoPediatrics	$212.45M	2.57	N/A	N/A	$14.64 per share	1.53
RXST RxSight	$139.93M	3.83	N/A	N/A	$6.98 per share	1.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVR Anteris Technologies Global	-$76.29M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
AXGN AxoGen	-$9.96M	-$0.15	N/A	N/A	N/A	-3.68%	-7.09%	-3.67%	8/6/2025 (Estimated)
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)
RXST RxSight	-$27.45M	-$0.67	N/A	N/A	N/A	-17.90%	-9.54%	-8.51%	8/4/2025 (Estimated)

Latest AVR, KIDS, RXST, and AXGN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2025	Q1 2025	AVR Anteris Technologies Global	N/A	-$0.61	N/A	-$0.61	N/A	N/A
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/7/2025	Q1 2025	RXST RxSight	-$0.03	-$0.03	N/A	-$0.20	$38.74 million	$37.90 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVR Anteris Technologies Global	N/A	N/A	N/A	N/A	N/A
AXGN AxoGen	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
RXST RxSight	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVR Anteris Technologies Global	N/A	3.67	3.65
AXGN AxoGen	0.63	4.28	2.65
KIDS OrthoPediatrics	0.21	6.19	2.99
RXST RxSight	N/A	12.68	11.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVR Anteris Technologies Global	N/A
AXGN AxoGen	80.29%
KIDS OrthoPediatrics	69.05%
RXST RxSight	78.78%

Insider Ownership

Company	Insider Ownership
AVR Anteris Technologies Global	N/A
AXGN AxoGen	2.78%
KIDS OrthoPediatrics	32.70%
RXST RxSight	9.57%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVR Anteris Technologies Global	138	36.06 million	N/A	N/A
AXGN AxoGen	450	45.54 million	44.28 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.35 million	Optionable
RXST RxSight	220	40.64 million	36.75 million	Optionable

AVR, KIDS, RXST, and AXGN Headlines

Recent News About These Companies

FMS vs. RXST: Which Stock Is the Better Value Option?

July 4 at 12:41 PM | zacks.com

RxSight, Inc. (RXST) stock price, news, quote & history - Yahoo Finance

June 30, 2025 | au.finance.yahoo.com

SG Americas Securities LLC Buys Shares of 36,267 RxSight, Inc. (NASDAQ:RXST)

June 19, 2025 | marketbeat.com

FMS or RXST: Which Is the Better Value Stock Right Now?

June 18, 2025 | zacks.com

RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of "Hold" by Analysts

June 15, 2025 | marketbeat.com

RxSight (NASDAQ:RXST) Trading Down 5.6% - Here's Why

June 11, 2025 | marketbeat.com

RxSight: Valuation Blowout Creates Opportunity

June 7, 2025 | seekingalpha.com

Do Options Traders Know Something About RxSight Stock We Don't?

May 23, 2025 | msn.com

5RXST : Deep Dive Into RxSight Stock: Analyst Perspectives (13 Ratings)

May 20, 2025 | benzinga.com

RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum

May 20, 2025 | globenewswire.com

RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price

May 10, 2025 | finance.yahoo.com

Earnings call transcript: RxSight reports Q1 2025 earnings beat, stock rises 6.67%

May 9, 2025 | investing.com

RxSight, Inc. Reports 28% Revenue Growth in Q1 2025, Highlights Strong Demand for Light Adjustable Lenses

May 9, 2025 | nasdaq.com

Top 3 Health Care Stocks That Are Preparing To Pump This Quarter

May 9, 2025 | benzinga.com

RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ...

May 8, 2025 | finance.yahoo.com

RxSight, Inc. Reports Strong Q1 2025 Revenue Growth

May 8, 2025 | tipranks.com

RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript

May 7, 2025 | seekingalpha.com

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

May 7, 2025 | zacks.com

RxSight, Inc. Reports First Quarter 2025 Financial Results

May 7, 2025 | finance.yahoo.com

RxSight’s Earnings Call: Growth Amid Challenges

May 6, 2025 | tipranks.com

RxSight, Inc. to Present at the Bank of America Healthcare Conference

April 30, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVR, KIDS, RXST, and AXGN Company Descriptions

Anteris Technologies Global NASDAQ:AVR

$3.80 +0.09 (+2.43%)

As of 07/3/2025 01:00 PM Eastern

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

AxoGen NASDAQ:AXGN

$10.92 -0.14 (-1.27%)

As of 07/3/2025 01:04 PM Eastern

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

OrthoPediatrics NASDAQ:KIDS

$22.46 +0.33 (+1.47%)

As of 07/3/2025 03:24 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

RxSight NASDAQ:RXST

$13.20 +0.06 (+0.45%)

Closing price 07/3/2025 03:35 PM Eastern

Extended Trading

$13.30 +0.10 (+0.76%)

As of 07/3/2025 04:01 PM Eastern

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time